Navigation Links
K-V Pharmaceutical Names Thomas McHugh Chief Financial Officer
Date:7/15/2010

for any additional costs they allegedly incurred for procuring products the Company did not supply;
  • the satisfaction or waiver of the terms and conditions for the acquisition of the full U.S. and worldwide rights to Gestiva™ set forth in the previously disclosed Gestiva™ acquisition agreement, as amended;
  • the series of putative class action lawsuits alleging violations of the federal securities laws by the Company and certain individuals, as more fully described in Note 18 – "Commitments and Contingencies – Litigation and Governmental Inquiries" of the Notes to the Consolidated Financial Statements in the Form 10-Q;
  • the possibility that insurance proceeds are insufficient to cover potential losses that may arise from litigation, including with respect to product liability, failure to supply or securities litigation;
  • the informal inquiry initiated by the SEC and any related or additional government investigation or enforcement proceedings as more fully described in Note 18 – "Commitments and Contingencies – Litigation and Government Inquiries, of the Notes to the Consolidated Financial Statements" in the Form 10-Q;
  • the possibility that the pending investigation by the Office of Inspector General of the Department of Health and Human Services into potential false claims under the Title 42 of the U.S. Code as more fully described in Note 18 – "Commitments and Contingencies – Litigation and Government Inquiries" of the Notes to the Consolidated Financial Statements in the Form 10-Q could result in significant civil fines or penalties, including exclusion from participation in federal healthcare programs such as Medicare and Medicaid;
  • delays in returning, or failure to return, certain or many of the Company's approved products to the market, including loss of market share as a result of the suspension of shipments, and related costs;
  • the ability to sell or license cert
    '/>"/>

  • SOURCE K-V Pharmaceutical Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
    2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
    9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... to their offering. Developed by Novo ... Novolog) is an important drug for the treatment ... as a fast- acting insulin analog, starts working ...
    (Date:8/28/2015)... Aug. 28, 2015  IP Shakti, LLC, today announced that ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... "Our new corporate identity signifies our transformation into a company ... analytics platform for patent claim validity." ... the proprietary AIA Shield™ platform, the Company commenced a corporate ...
    (Date:8/28/2015)... England and PITTSBURGH ... MYL ) today announced that its shareholders ... plc (NYSE: PRGO ; TASE) and the ... shareholders at an extraordinary general meeting of shareholders ... the votes cast at the extraordinary general meeting. ...
    Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9
    ... NEW YORK, May 24, 2011 As part ... integration of technology in clinics, hospitals and medical ... integration capabilities. Phreesia,s solution, used by over 10,000 ... automates the check-in process for patients and practice ...
    ... With 22 percent adoption among medical providers, as ... iPad has become a key tool for US doctors ... innovative practice models. Medical providers are increasingly looking to ... a rapidly changing medical sector. Practice Fusion has noted ...
    Cached Medicine Technology:Phreesia's Enhanced Integration Capabilities Provide Better Patient Management for Medical Practices 2iPad Supports Medical Practitioners on the Move 2iPad Supports Medical Practitioners on the Move 3
    (Date:8/28/2015)... ... , ... For Dallas, the time is nearing for the annual Heart Walk, ... , The American Heart Association hosts their well-known Heart Walk to raise money in ... difference can be made. Walkers can participate in the cause and someone can also ...
    (Date:8/28/2015)... , ... August 28, 2015 , ... ... or those who might personally be struggling with chemical dependency, may be able ... Best Drug Rehabilitation, a results-driven holistic treatment center for addiction located in Western ...
    (Date:8/28/2015)... ... August 28, 2015 , ... Medical Solutions, one of the nation’s largest ... Work in Healthcare by Modern Healthcare and will be honored at an awards ... eighth year, the Best Places to Work in Healthcare program recognizes outstanding employers in ...
    (Date:8/28/2015)... ... 2015 , ... The Quatela Center for Plastic Surgery is excited to bring ... product approved by the Food and Drug Administration to eliminate submental fat, also known ... Koenig are among the premier cosmetic surgeons in Rochester to offer this innovative ...
    (Date:8/28/2015)... ... August 28, 2015 , ... The ... health information technology innovation to transform quality and efficiency of healthcare delivery worldwide, ... be de-identified and aggregated before being publicly shared to document progress and inform ...
    Breaking Medicine News(10 mins):Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2
    ... ... marketing and website design firm based in San Diego, will be meeting with leaders ... the U.S. The Baker Gordon Educational Symposium invites plastic surgeons and medical professionals from around ... cosmetic enhancement. , ...
    ... ... of postmortem procedures , ... AZ (Vocus) February 4, 2010 -- Doctors or pathology technicians perform autopsies to diagnose any ... to the decedent’s death. The postmortem examination is of great importance to the family of ...
    ... Beauty blogging ... ... to get ready for Valentine,s Day ? Why not throw a party just for ... tailgating for Valentine’s Day., , ,Valentine’s Day isn’t just for couples anymore as all kinds ...
    ... ... a streamlined electronic document exchange process. , ... (PRWEB) February 4, 2010 -- GlobalSign Inc., ... for securing PDF documents, has today announced the success of GlobalSign’s digital signature ...
    ... ... how Howard I. Glazer Ph.D. uses the internet to share his expertise in the field ... ... Glazer Ph.D. will discuss how he shares his expertise in the field of Lower Gastrointestinal, ...
    ... , March of Dimes Awards Abstract at ... New evidence that genetics play a significant role in ... everything right and still give birth too soon. , Research ... meeting ― The Pregnancy Meeting™ ― showed that the genes of ...
    Cached Medicine News:Health News:Plastic Surgery Website Design Firm Rosemont Media Heads to Miami for the 44th Annual Baker Gordon Symposium 2Health News:Plastic Surgery Website Design Firm Rosemont Media Heads to Miami for the 44th Annual Baker Gordon Symposium 3Health News:Author Presents a Practical Guide for Postmortem Examinations 2Health News:Valentine Tailgate Party for the Girls with Festive Ideas from Beauty Research 2Health News:Euthymics Bioscience Collaborates with GlobalSign and SafeNet to Provide an FDA Approved Electronic Signature Solution 2Health News:Euthymics Bioscience Collaborates with GlobalSign and SafeNet to Provide an FDA Approved Electronic Signature Solution 3Health News:Euthymics Bioscience Collaborates with GlobalSign and SafeNet to Provide an FDA Approved Electronic Signature Solution 4Health News:Euthymics Bioscience Collaborates with GlobalSign and SafeNet to Provide an FDA Approved Electronic Signature Solution 5Health News:International Pelvic Floor Muscle Expert Presents Live Webinars on Telemedecine 2Health News:International Pelvic Floor Muscle Expert Presents Live Webinars on Telemedecine 3Health News:New Research Shows Genes of Pregnant Women and Their Fetuses Can Increase the Risk of Preterm Labor 2Health News:New Research Shows Genes of Pregnant Women and Their Fetuses Can Increase the Risk of Preterm Labor 3
    Large image and wide-angle design....
    ... cornea surgery is a procedure for restoring ... damaged anterior segment due to trauma, chemical ... will be supplied on special request only.,The ... trephine REF OK102, needles and stainless steel ...
    Calculate accurate growth percentiles and Z scores using the latest CDC growth charts....
    PDA-version of the complete ICD-9 diagnosis codes....
    Medicine Products: